What is Cerulean Associates?
Cerulean Associates operates as a specialized consultancy firm dedicated to the complex requirements of FDA-regulated entities. With a core focus on Lean FDA Quality System Standard Operating Procedures, data integrity, and rigorous recordkeeping, the firm serves as a critical partner for contract laboratories and manufacturing organizations. Beyond standard consulting, Cerulean provides high-stakes mock FDA audits and comprehensive training programs designed to mitigate operational risk. Their expertise extends to litigation support, where they provide technical guidance on quality systems and regulatory compliance, effectively bridging the gap between operational efficiency and strict adherence to federal mandates.
How much funding has Cerulean Associates raised?
Cerulean Associates has raised a total of $15K across 1 funding round:
Debt
$15K
Debt (2021): $15K with participation from PPP
Key Investors in Cerulean Associates
PPP
Public-Private Partnership
What's next for Cerulean Associates?
With the recent injection of capital, Cerulean Associates is poised to expand its service offerings and deepen its market penetration within the pharmaceutical and medical device sectors. The strategic deployment of these funds will likely focus on enhancing their digital compliance tools and scaling their audit readiness programs to meet the evolving demands of global regulatory bodies. As the firm transitions through its current growth stage, the focus remains on solidifying its reputation as a premier authority in quality system optimization, ultimately driving long-term value for its diverse portfolio of life science clients.
See full Cerulean Associates company page
